| Authors: |
Camacho N; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, United Kingdom.; Department of Human Genetics, University of Leuven, Leuven, Belgium., Edwards S; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom., Kay JD; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom., Matthews L; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom., Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London, United Kingdom., Clark J; Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom., Dennis N; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Thomas S; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Kremeyer B; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Zamora J; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Butler AP; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Gundem G; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.; Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America., Merson S; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom., Luxton H; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom., Hawkins S; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom., Ghori M; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Marsden L; Department of Physiology, University of Oxford, Oxford, Oxfordshire, United Kingdom., Lambert A; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, Oxfordshire, United Kingdom., Karaszi K; Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, Oxfordshire, United Kingdom.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom., Pelvender G; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom., Massie CE; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; CRUK Cambridge Centre, Early Detection Programme, Urological Malignancies Programme, Hutchison-MRC Research Centre, Cambridge, Cambridgeshire, United Kingdom., Kote-Jarai Z; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom., Raine K; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Jones D; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Howat WJ; Histopathology and in situ hybridization Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom., Hazell S; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Livni N; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Fisher C; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Ogden C; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Kumar P; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Thompson A; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Nicol D; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Mayer E; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Dudderidge T; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Yu Y; Department of Epidemiology, Second Military Medical University, Shanghai, China., Zhang H; Department of Epidemiology, Second Military Medical University, Shanghai, China., Shah NC; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom., Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom., Isaacs W; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America., Visakorpi T; Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere and Tampere University Hospital, Tampere, Finland., Hamdy F; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom., Berney D; Centre for Molecular Oncology, Barts Cancer Institute, The Barts and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Verrill C; Department of Cellular Pathology and Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom., Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom., Wedge DC; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.; Oxford Big Data Institute & Oxford Centre for Cancer Gene Research, Wellcome Trust Centre for Human Genetics, Oxford, Oxfordshire, United Kingdom., Lynch AG; Statistics and Computational Biology Laboratory, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; School of Mathematics and Statistics/School of Medicine, University of St Andrews, St Andrews, Fife, Scotland., Foster CS; HCA Pathology Laboratories, HCA Healthcare, London, United Kingdom., Lu YJ; Centre for Molecular Oncology, Barts Cancer Institute, The Barts and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Bova GS; Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere and Tampere University Hospital, Tampere, Finland., Whitaker HC; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Molecular Diagnostics and Therapeutics Group, University College London, London, United Kingdom., McDermott U; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom., Neal DE; Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, Cambridgeshire, United Kingdom.; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom., Eeles R; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom., Cooper CS; Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, United Kingdom.; Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom., Brewer DS; Norwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.; Organisms and Ecosystems, The Earlham Institute, Norwich, Norfolk, United Kingdom. |
